| ARES |
Report |
After-tax realized EPS |
BEAT |
pred ~$1.35 vs. cons $1.30 |
MEDIUM |
| ARES |
Report |
Fee-related earnings |
BEAT |
pred ~$495M vs. cons $487M |
MEDIUM |
| ARES |
Report |
Management fees |
BEAT |
pred ~$1.092B vs. cons $1.080B |
LOW |
| ARES |
Guide |
Fee-related earnings growth |
BETTER |
guide ~20% vs. cons 19% (FY2026) |
MEDIUM |
| ARES |
Guide |
Fee-related earnings margin expansion |
BETTER |
guide ~140 bps vs. cons 125 bps (FY2026) |
MEDIUM |
| ARES |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| ARES |
Return |
5-day cumulative residual |
+4.6% (FOLLOW-THROUGH) |
Above-consensus management fees and FRE, plus FY2026 growth of ~20% versus consensus of 19%, should lift FY2026-FY2027 estimates; limited deployment acceleration and wealth-redemption concerns cap the follow-through. |
LOW |